Aletho News

ΑΛΗΘΩΣ

US Surgeon General advises “clear consequences” for online “misinformation super-spreaders”

By Didi Rankovic | Reclaim the Net | July 16, 2021

The US Department of Health and Human Services (HHS) has released its general Covid advisory on “confronting health misinformation” signed by US Surgeon General Vivek H. Murthy.

We obtained a copy of the report for you here.

For the purposes of the advisory, health misinformation is defined as information that is false, inaccurate, or misleading “according to the best available evidence at the time.”

And among those who are urged and given suggestions on how to act to suppress this kind of information are technology platforms, who are advised to devise “clear consequences” for users who are branded as “misinformation super-spreaders.”

Technology platforms are told to assess the benefits and harms of their platforms and products, and then “take responsibility for addressing the harms.”

And those who are found to be “super-spreaders” and “repeat offenders” in posting misinformation should be faced with “clear consequences” that tech platforms are supposed to devise and impose on their users.

Tech companies are also expected to commit to long-term investments for the purpose combating misinformation that can include changing their products – such as redesigning recommendation algorithms. The idea here is to tweak these algorithms so that unwanted medical information is down ranked and difficult to discover.

The surgeon general also wants tech platforms to put more “frictions” in place – like labels and warnings that now appear on many social media posts in order to dissuade users from interacting with the content in question, or direct them towards “trusted sources.”

Next, unspecified researchers should be given access to Big Tech’s data so that they can learn “what people see and hear, not just what they engage with.” Another reason is for “researchers” to be sure how platforms are moderating and censoring content – some methods mentioned are labeling, removing, and downranking.

Privacy is also paid lip service in a remark that says user data “can be” anonymized while provided with user consent – but the advisory is not explicit that this “must be” the case.

And not all medical (mis)information is happening in English, so these US platforms are recommended to “increase staffing of multilingual content moderation teams and improve the effectiveness of machine learning algorithms in languages other than English.”

The advisory also wants platforms to amplify, i.e. direct users even more aggressively towards “trusted and credible sources” and those who are accepted as experts.

Then there’s – as the advisory phrased it – the “unintended consequences” of censorship. And that’s not about free speech suppression or anything similar – it’s “migration of users to less-moderated platforms.”

And that is another thing, the US surgeon general writes, that tech platforms should “work to understand.”

July 17, 2021 Posted by | Civil Liberties, Full Spectrum Dominance | , | 2 Comments

AUSTRALIA: DON’T TELL PEOPLE THEY’RE SCREWED IF VAXX MAKES THEM SICK

https://www.bitchute.com/video/7iApRiu3DtjS/

June 28, 2021

Secret video of senate meeting with head of TGA Brendan Murphy telling Parliament to not tell the public of their own vaccine effects coverup and that the vaccine kills people and they have no recourse from it because the government granted big pharma immunity from prosecution and compensation payouts!

July 17, 2021 Posted by | Video | , | 3 Comments

2017 article in a Nature journal discusses ivermectin effects (even against cancer) and mechanisms of action

By Meryl Nass, MD | July 14, 2021

Someone wrote this in 2017. Some people thus knew ivermectin had antiviral properties. In fact, the drug has all kinds of possibly miraculous effects. It is just missing the important one: patentability. (It was patented but the patent expired in 1997.)

Recent research has confounded the belief, held for most of the past 40 years, that ivermectin was devoid of any antiviral characteristics. Ivermectin has been found to potently inhibit replication of the yellow fever virus, with EC50 values in the sub-nanomolar range. It also inhibits replication in several other flaviviruses, including dengue, Japanese encephalitis and tick-borne encephalitis, probably by targeting non-structural 3 helicase activity.97 Ivermectin inhibits dengue viruses and interrupts virus replication, bestowing protection against infection with all distinct virus serotypes, and has unexplored potential as a dengue antiviral.98 Ivermectin has also been demonstrated to be a potent broadspectrum specific inhibitor of importin α/β-mediated nuclear transport and demonstrates antiviral activity against several RNA viruses by blocking the nuclear trafficking of viral proteins. It has been shown to have potent antiviral action against HIV-1 and dengue viruses, both of which are dependent on the importin protein superfamily for several key cellular processes. Ivermectin may be of import in disrupting HIV-1 integrase in HIV-1 as well as NS-5 (non-structural protein 5) polymerase in dengue viruses.99,100…

Anti-cancer 

There is a continuously accumulating body of evidence that ivermectin may have substantial value in the treatment of a variety of cancers. The avermectins are known to possess pronounced antitumor activity,107 as well as the ability to potentiate the antitumor action of vincristine on Ehrlich carcinoma, melanoma B16 and P388 lymphoid leukemia, including the vincristine-resistant strain P388.108 Over the past few years, there have been steadily increasing reports that ivermectin may have varying uses as an anti-cancer agent, as it has been shown to exhibit both anti-cancer and anti-cancer stem cell properties. An in silico chemical genomics approach designed to predict whether any existing drugs might be useful in tackling glioblastoma, lung and breast cancer, indicated that ivermectin may be a useful compound in this respect.109 In human ovarian cancer and NF2 tumor cell lines, high-dose ivermectin inactivates protein kinase PAK1 and blocks PAK1- dependent growth. PAK proteins are essential for cytoskeletal reorganization and nuclear signaling, PAK1 being implicated in tumor genesis while inhibiting PAK1 signals induces tumor cell apoptosis (cell death). PAK1 is essential for the growth of more than 70% of all human cancers, including breast, prostate, pancreatic, colon, gastric, lung, cervical and thyroid cancers, as well as hepatoma, glioma, melanoma, multiple myeloma and for neurofibromatosis tumors.110 Globally, breast cancer is the most common cancer among women but treatment options are few. Ivermectin suppresses breast cancer by activating cytostatic autophagy, disrupting cellular signaling in the process, probably by reducing PAK1 expression… https://www.nature.com/articles/ja201711.pdf

July 17, 2021 Posted by | Timeless or most popular | | Leave a comment

    Next Entries »